On Friday, April 23, 2021, the CDC and FDA announced they would accept the Advisory Committee on Immunization Practices’ (ACIP) recommendations to lift pausing on the Johnson & Johnson COVID-19 vaccine for all adults.
On Friday, April 23, 2021, the CDC and FDA announced they would accept the Advisory Committee on Immunization Practices’ (ACIP) recommendations to lift pausing on the Johnson & Johnson COVID-19 vaccine for all adults.